Original work

2025: 'Childhood-onset RASopathy-associated hypertrophic cardiomyopathy is associated with progressive left atrial dilatation, diastolic impairment and complex atrial arrhythmias' (Boleti)
2025: ' Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events' (Boleti)
2025: 'Impact of MEK Inhibition on Childhood RASopathy-Associated Hypertrophic Cardiomyopathy' (Wolf)
2024: 'Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry' (Kaski)
2022: 'Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management' (Limongelli)
2022: Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking' (Parisi)